Life Tech, Gen-Probe to Collaborate on FDA Clearance for Dx Assays on CE Sequencer

Under the agreement, Gen-Probe will commercialize future diagnostic tests — based on DNA sequencing or DNA fragment analysis — that will run on Life Tech's 3500 Dx Genetic Analyzer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.